Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Times New Jersey.
Press releases published on August 28, 2025
Moleculin Announces Exercise of Warrants for $6.0 Million Gross Proceeds
GlobeNewswire
·
August 28, 2025
HOUSTON, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today announced it …
SEALSQ Enhances INeS PKI Platform with Code Signing Capability to Secure Firmware Integrity in Alignment with RED and CRA Regulations
GlobeNewswire
·
August 28, 2025
Geneva, Switzerland, Aug. 28, 2025 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, today announced a …
Alarum Technologies Announces Second Quarter 2025 Results
GlobeNewswire
·
August 28, 2025
Deepening collaborations with major global customers while accelerating investments in technology and talent to cement Alarum’s key positioning in the AI value chain Q2 2025 revenues of $8.8 million, net profit of $0.3 million, and Adjusted EBITDA of $1.0 …
NurExone Biologic Inc. Announces Second Quarter 2025 Financial Results
GlobeNewswire
·
August 28, 2025
TORONTO and HAIFA, Israel, Aug. 28, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a preclinical-stage biotechnology company pioneering exosome-based therapies for central nervous system …
CryptoVirally Expands Web3 Marketing Services, Unifying PR, KOLs, and Community Growth Into One Full-Funnel Program
GlobeNewswire
·
August 28, 2025
Bucharest, Romania, Aug. 28, 2025 (GLOBE NEWSWIRE) -- CryptoVirally today announced an expanded suite of crypto marketing and Web3 marketing solutions that combine press releases, media placements, influencer and KOL activations, community growth, and …
Candel Therapeutics to Participate in Upcoming Investor Conferences in September
GlobeNewswire
·
August 28, 2025
NEEDHAM, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, …
IMUNON Successfully Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement
GlobeNewswire
·
August 28, 2025
LAWRENCEVILLE, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy, today announced that the Company has regained compliance with the minimum bid price …
Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 28, 2025
CORAL GABLES, Fla., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for …
EXL to participate in Citi Global TMT Conference in New York
GlobeNewswire
·
August 28, 2025
NEW YORK, Aug. 28, 2025 (GLOBE NEWSWIRE) -- ExlService Holdings, Inc., (NASDAQ: EXLS) announced today that Vivek Jetley, president and head of Insurance, Healthcare and Life Sciences and Maurizio Nicolelli, chief financial officer, will present at the Citi …
Biptap Expands to Africa with Central African Republic Deal
GlobeNewswire
·
August 28, 2025
Dubai, UAE , Aug. 28, 2025 (GLOBE NEWSWIRE) -- Biptap expands to Africa with a landmark partnership in the Central African Republic, marking a major step toward redefining financial access across the continent. The deal, signed between Biptap CEO Jonathan …
Tidewave Bio Completes FDA INTERACT Meeting for TBC-1, a Universal Cell Therapy Platform in Solid Tumors
GlobeNewswire
·
August 28, 2025
LOS ANGELES, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Tidewave Bio, a biotechnology company developing a universal, off-the-shelf, gene-enhanced antigen-presenting cell therapy platform, today announced the successful completion of its FDA INTERACT meeting. This …
CytomX Therapeutics to Present at Upcoming September Investor Conferences
GlobeNewswire
·
August 28, 2025
SOUTH SAN FRANCISCO, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that management will participate in the following investor …
ARS Pharmaceuticals to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 28, 2025
SAN DIEGO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect themselves from allergic reactions that could lead to …
Collegium to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 28, 2025
STOUGHTON, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that its management will participate in the following investor conferences: 2025 Wells Fargo Healthcare Conference Thursday, September 4, 2025 …
Easily Integrate Position, Navigation and Timing Technology With Microchip’s Portfolio of GNSS Disciplined Oscillator Modules
GlobeNewswire
·
August 28, 2025
CHANDLER, Ariz., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Aerospace and defense applications rely on Position, Navigation and Timing (PNT) technology for mission-critical accuracy and reliability. However, integrating PNT into a design requires extensive domain …
Kyverna Therapeutics Highlights Neuroimmunology CAR T Franchise and Registrational Phase 3 Trial Design in Myasthenia Gravis at Virtual KOL Event
GlobeNewswire
·
August 28, 2025
KYV-101 has the potential to deliver durable, drug-free, disease-free remission in myasthenia gravis and set a new treatment standard for stiff person syndrome Innovative FDA-aligned KYSA-6 Phase 3 trial design for myasthenia gravis supports clear and …
Fusemachines to Present at the 2025 Annual Gateway Conference on September 3rd
GlobeNewswire
·
August 28, 2025
NEW YORK, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Fusemachines, Inc. (“Fusemachines” or the “Company”), a leading provider of enterprise AI products and services, today announced its upcoming attendance of the 2025 Annual Gateway Conference, an institutional …
TG Therapeutics to Participate in the Cantor Global Healthcare Conference
GlobeNewswire
·
August 28, 2025
NEW YORK, Aug. 28, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in the Cantor Global Healthcare Conference, being held in New York, …
RentRedi Delivers Fast, Flexible Financing, powered by Stripe Capital
GlobeNewswire
·
August 28, 2025
NEW YORK, Aug. 28, 2025 (GLOBE NEWSWIRE) -- RentRedi, the fastest-growing property management software for smart real estate investors, today announced the launch of a new financing solution powered by Stripe Capital that provides fast, flexible funding to …
NETCLASS TECHNOLOGY INC Announces Headquarters Relocation to Singapore and Planned Acquisition of Vietnam-based LBC International Company Limited
GlobeNewswire
·
August 28, 2025
SHANGHAI and HONG KONG, Aug. 28, 2025 (GLOBE NEWSWIRE) -- NETCLASS Technology INC (Nasdaq: NTCL; the “Company” or “NetClass”), a leading B2B smart education IT solutions provider with offices in Shanghai, Hong Kong, Singapore and Tokyo, today announced …